Perrigo CoSTU:PIG -0.82%47 Market Cap is €1,221 Mil as of Jun. 30, 2026. GuruFocus rates STU:PIG with a GF Score™ of 47/100 and a GF Value™ of €21.62 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,020 Drug Manufacturers companies, Perrigo Co ranks better than 80.1% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Perrigo Co's share price for the quarter that ended in Mar. 2026 was €9.272. Perrigo Co's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 138 Mil. Therefore, Perrigo Co's market cap for the quarter that ended in Mar. 2026 was €1,280 Mil.
Perrigo Co's quarterly market cap
declined
from Sep. 2025 (€2,525 Mil) to Dec. 2025 (€1,607 Mil) and
declined
from Dec. 2025 (€1,607 Mil) to Mar. 2026 (€1,280 Mil).
Perrigo Co's annual market cap
declined
from Dec. 2023 (€3,919 Mil) to Dec. 2024 (€3,326 Mil) and
declined
from Dec. 2024 (€3,326 Mil) to Dec. 2025 (€1,607 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Perrigo Co's Enterprise Value for Today is €4,097 Mil.
Perrigo Co (STU:PIG) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Perrigo Co Market Cap Related Terms
Perrigo Co Market Cap Historical Data
* Premium members only.
The historical data trend for Perrigo Co's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:PIG vs XERS, PAHC, ALVO: Market Cap Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Perrigo Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Perrigo Co Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Perrigo Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Perrigo Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Perrigo Co's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Perrigo Co (STU:PIG) has a Market Cap of €1,221 Mil as of Jun. 30, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Perrigo Co and its competitors. According to the industry distribution chart, Perrigo Co ranks #203 out of 1020 companies in the Drug Manufacturers industry, placing it in the top 19.9%.
Is Perrigo Co's Market Cap too high?
Perrigo Co's current Market Cap is €1,221 Mil. Based on the distribution chart, Perrigo Co ranks #203 out of 1020 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Perrigo Co has a GF Score™ of 47/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Perrigo Co's Market Cap compare to XERS and PAHC?
According to the Drug Manufacturers industry distribution chart, Perrigo Co ranks #203 out of 1020 companies for Market Cap. This places Perrigo Co in the top 20% of its industry — outperforming the majority of peers. The industry median Market Cap is 213.67. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 213.67, based on 1,020 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Perrigo Co and its competitors. For the Drug Manufacturers industry, the median Market Cap is 213.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Perrigo Co's current Market Cap is €1,221 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Perrigo Co stock overvalued right now?
Based on GuruFocus' analysis, Perrigo Co (STU:PIG) is currently considered Possible Value Trap. The stock's GF Value™ is €21.62, compared to a current price of €8.69 — trading 59.8% below its estimated fair value. The current Market Cap is €1,221 Mil. Perrigo Co's overall GF Score™ is 47/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Perrigo Co (STU:PIG), the current Market Cap is €1,221 Mil as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Perrigo Co (STU:PIG) Overvalued in 2026?
Based on GuruFocus' analysis, Perrigo Co stock appears to be undervalued.
The current stock price of €8.69 is trading 59.8% below its estimated GF Value™ of €21.62.
GuruFocus considers Perrigo Co to be Possible Value Trap.
Key valuation signals for STU:PIG:
Market Cap: €1,221 Mil
GF Value™: €21.62 vs. price of €8.69 (59.8% below fair value)
No single metric tells the full story. See the STU:PIG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
47GF Score
Get the complete analysis for STU:PIG
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:PIG has been successfully added to your 
